Relapse markers in childhood thyrotoxicosis.

Area of Science:

• Pediatric Endocrinology
• Thyroid Disorders

Background:

• Childhood thyrotoxicosis, often due to Graves disease, presents a significant challenge due to high relapse rates with medical management.
• Identifying predictive markers for relapse is crucial for optimizing treatment strategies in pediatric patients.

Purpose of the Study:

• To investigate clinical and biochemical markers associated with relapse in childhood thyrotoxicosis.
• To identify predictors of treatment failure and recurrence in pediatric Graves disease.

Main Methods:

• A cohort of 32 pediatric patients diagnosed with Graves disease was analyzed.
• Clinical features including goiter size, ophthalmopathy, serum thyroxine levels, and history of previous relapse were correlated with relapse rates.

Main Results:

• Goiter size (≥2x normal), presence of ophthalmopathy, serum thyroxine levels (>20 mcg/dl), and a history of previous relapse were significantly associated with a higher likelihood of relapse.
• Factors such as sex, family history, and antibody status did not show a significant correlation with relapse.

Conclusions:

• Goiter size, ophthalmopathy, elevated thyroxine levels, and prior relapse are significant predictors of relapse in childhood thyrotoxicosis.
• These findings can aid in stratifying risk and tailoring treatment approaches for pediatric Graves disease.